Match tier Listed
Presence Current · Arkansas
Last published 2024
Sources OpenAlex · ORCID
Refreshed 2026-08-15

William Bellamy

High Impact

Researcher

Also affiliated: City Of Hope National Medical Center (2005); University of Arizona (1988–2006); Johns Hopkins University (2020); Prudential Financial (United States) (2018); University of South Florida (2004); University of Arkansas Medical Center (2017); Arizona Science Center (1992); Moffitt Cancer Center (2004–2006); Public Health England (2007–2014); University of Illinois Chicago (2005); Biology of Infection (2007); City of Hope (2005); Health Protection Agency (2014); Palmetto Hematology Oncology (2004); Banner - University Medical Center Tucson (1996); Ventana Research Corporation (United States) (2000); University of Virginia Medical Center (1983); Arizona Cancer Therapeutics (United States) (1988–1989); Arizona Oncology (1988–2001); University of Arizona Cancer Center (2000); University of Virginia (1982); University of Cincinnati (2000)

Faculty Researcher

30 h-index 93 pubs 4,762 cited

  • Humans
  • Animals
  • Multiple Myeloma
  • Tumor Cells, Cultured
  • Male
  • Female
  • Drug Resistance, Multiple
  • Antineoplastic Agents
  • Aged
  • Drug Resistance
  • Middle Aged
  • Mice
  • Doxorubicin
  • Gene Expression Regulation, Neoplastic
  • Vascular Endothelial Growth Factor A

Biography and Research Information

OverviewAI-generated summary

William Bellamy is a researcher at the University of Arkansas for Medical Sciences with a focus on disease mechanisms and microbial infections. His work has led to 93 total publications, which have been cited approximately 4,756 times, contributing to an h-index of 30. Bellamy is recognized as a highly cited researcher. His recent publication in 2024 investigates the role of plasmid-encoded genes in the enzootic cycle of *Borrelia burgdorferi*. He has collaborated with colleagues including Jon S. Blevins, Brendan P. Moore, and Nora E. Gibbons, all from the University of Arkansas for Medical Sciences, on shared publications.

Metrics

  • h-index: 30
  • Publications: 93
  • Citations: 4,762

Selected Publications

  • The plasmid-encoded members of paralogous gene family 52 are dispensable to the enzootic cycle of <i>Borrelia burgdorferi</i> (2024)
    Infection and Immunity 1 citation DOI OpenAlex
  • Analysis of primary central nervous system large B-cell lymphoma in the era of high-grade B-cell lymphoma: Detection of two cases with MYC and BCL6 rearrangements in a cohort of 12 cases (2020)
    Annals of Diagnostic Pathology 7 citations DOI OpenAlex
  • ALK Rearrangements Are Infrequent in Cellular Blue Nevus and Deep Penetrating Nevus (2018)
    American Journal of Dermatopathology 4 citations DOI OpenAlex
  • Short-Duration Rapid Chilling of Mastectomy Specimens Does Not Interfere With Breast Cancer Biomarker and Molecular Testing (2018)
    Archives of Pathology & Laboratory Medicine 2 citations DOI OpenAlex
  • The level of deletion 17p and bi-allelic inactivation of <i>TP53</i> has a significant impact on clinical outcome in multiple myeloma (2017)
    Haematologica 78 citations DOI OpenAlex
  • BB0238, a Presumed Tetratricopeptide Repeat-Containing Protein, Is Required during Borrelia burgdorferi Mammalian Infection (2014)
    Infection and Immunity 26 citations DOI OpenAlex
  • Chitosan coating to enhance the therapeutic efficacy of calcium sulfate-based antibiotic therapy in the treatment of chronic osteomyelitis (2014)
    Journal of Biomaterials Applications 54 citations DOI OpenAlex
  • Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients (2014)
    Journal of Immunotherapy 182 citations DOI OpenAlex
  • Highly activated and expanded natural killer cells for multiple myeloma immunotherapy (2012)
    Haematologica 107 citations DOI OpenAlex
  • Use of Xylitol To Enhance the Therapeutic Efficacy of Polymethylmethacrylate-Based Antibiotic Therapy in Treatment of Chronic Osteomyelitis (2012)
    Antimicrobial Agents and Chemotherapy 26 citations DOI OpenAlex
  • Evaluation of Dynamic [18F]-FDG-PET Imaging for the Detection of Acute Post-Surgical Bone Infection (2012)
    PLoS ONE 25 citations DOI OpenAlex
  • Autologous Expanded Natural Killer Cells As a New Therapeutic Option for High-Risk Myeloma (2011)
    Blood DOI OpenAlex
  • Phase II randomized trial of bevacizumab <i>versus</i> bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial (2011)
    British Journal of Haematology 47 citations DOI OpenAlex
  • A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108 (2009)
    Leukemia & lymphoma/Leukemia and lymphoma 104 citations DOI OpenAlex
  • Expression of Myeloma-Specific Markers in Bone Marrow Spicules Using a Novel Immunohistochemical Technique (2008)
    Blood DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

4 Collaborators 4 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics